Prelude Capital Management’s Cogentix Medical, Inc. CGNT Stock Holding History

Prelude Capital Management’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-38,309	Closed	-$147K	–	2139
2018 Q1	$147K	Buy	+38,309	New	+$120K	0.01%	765

Prelude Capital Management's CGNT Position: Q2 2018 in Review

Prelude Capital Management sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 38,309 shares — an estimated $147K sold.

Prelude Capital Management first reported a position in CGNT in Q1 2018 and held it in 1 quarter. The position peaked at $147K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Prelude Capital Management reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Prelude Capital Management sold 38,309 Cogentix Medical, Inc. shares in Q2 2018, an estimated $147K.
Prelude Capital Management first reported a position in Cogentix Medical, Inc. in Q1 2018 and held it in 1 quarter.
Prelude Capital Management's Cogentix Medical, Inc. position peaked at $147K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Prelude Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.